» Articles » PMID: 22448610

Prevalence, Symptoms and Management of Uterine Fibroids: an International Internet-based Survey of 21,746 Women

Overview
Publisher Biomed Central
Date 2012 Mar 28
PMID 22448610
Citations 169
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In 2009 the Uterine Bleeding and Pain Women's Research Study (UBP-WRS) was conducted interviewing 21,479 women across 8 countries in order to gain patient-based prevalence data on uterine pain and bleeding indications and investigate uterine symptoms and women's treatment experiences. This article shows relevant results of the study for the indication uterine fibroids providing data on self-reported prevalence, symptomatology and management of uterine fibroids.

Methods: 2,500 women (USA: 4,500 women) in each country (Brazil, Canada, France, Germany, Italy, South Korea, the UK, the USA) completed an online survey. Women included were in their reproductive age (age group 15-49 years; USA: 18-49 years) and had ever experienced menstrual bleedings. Quotas were applied for age, region, level of education and household income of respondents. Variables have been analyzed descriptively and exploratory statistical tests have been performed.

Results: The self-reported prevalence of uterine fibroids ranged from 4.5% (UK) to 9.8% (Italy), reaching 9.4% (UK) to 17.8% (Italy) in the age group of 40-49 years. Women with a diagnosis of uterine fibroids reported significantly more often about bleeding symptoms than women without a diagnosis: heavy bleedings (59.8% vs. 37.4%), prolonged bleedings (37.3% vs. 15.6%), bleeding between periods (33.3% vs. 13.5%), frequent periods (28.4% vs. 15.2%), irregular and predictable periods (36.3% vs. 23.9%). Furthermore women with diagnosed uterine fibroids reported significantly more often about the following pain symptoms: pressure on the bladder (32.6% vs. 15.0%), chronic pelvic pain (14.5% vs. 2.9%), painful sexual intercourse (23.5% vs. 9.1%) and pain occurring mid-cycle, after and during menstrual bleeding (31.3%, 16.7%, 59.7%, vs. 17.1%, 6.4%, 52.0%). 53.7% of women reported that their symptoms had a negative impact on their life in the last 12 month, influencing their sexual life (42.9%), performance at work (27.7%) and relationship & family (27.2%).

Conclusions: Uterine fibroid is a common concern in women at fertile age causing multiple bleeding and pain symptoms which can have a negative impact on different aspects in women's life.

Citing Articles

Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups.

Kim J, Williams A, Noh H, Jasper E, Jones S, Jaworski J Nat Commun. 2025; 16(1):2273.

PMID: 40050615 PMC: 11885530. DOI: 10.1038/s41467-025-57483-5.


A systematic review and meta-analysis comparing the use of elagolix therapy alone or in combination with add-back therapy to treat women with uterine fibroid associated heavy menstrual bleeding.

Wang X, Li J, Liu Y, Zheng Y, Wang X, Liu G Gland Surg. 2025; 14(1):60-73.

PMID: 39958902 PMC: 11826254. DOI: 10.21037/gs-24-386.


Epidemiological features of uterine fibroid-associated imaging changes in Chinese women of reproductive age: a retrospective study.

Zhang L, Xu F, Huang Y, Xu W, Pu Y, Chen K BMJ Open. 2025; 15(1):e085671.

PMID: 39773792 PMC: 11749307. DOI: 10.1136/bmjopen-2024-085671.


The Burden of Pain Symptoms in Individuals with Uterine Fibroids-Results from a Prospective Observational Study in the USA.

Hunsche E, Marshall N, See J, Rakov V, Levy B Int J Womens Health. 2024; 16:2247-2261.

PMID: 39722793 PMC: 11669481. DOI: 10.2147/IJWH.S481790.


Exploring Self-Reported Symptoms for Developing and Evaluating Digital Symptom Checkers for Polycystic Ovarian Syndrome, Endometriosis, and Uterine Fibroids: Exploratory Survey Study.

Wickham A, Hewings-Martin Y, Goddard F, Rodgers A, Cunningham A, Prentice C JMIR Form Res. 2024; 8:e65469.

PMID: 39666967 PMC: 11672639. DOI: 10.2196/65469.


References
1.
Shikora S, Niloff J, Bistrian B, Forse R, Blackburn G . Relationship between obesity and uterine leiomyomata. Nutrition. 1991; 7(4):251-5. View

2.
Farquhar C, Steiner C . Hysterectomy rates in the United States 1990-1997. Obstet Gynecol. 2002; 99(2):229-34. DOI: 10.1016/s0029-7844(01)01723-9. View

3.
Chen C, Buck G, COUREY N, Perez K, Wactawski-Wende J . Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol. 2001; 153(1):20-6. DOI: 10.1093/aje/153.1.20. View

4.
Syrop C, Stovall D, Van Voorhis B . Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol. 1999; 94(4):516-20. DOI: 10.1016/s0029-7844(99)00345-2. View

5.
Andersen J . Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrinol. 1996; 14(3):269-82. DOI: 10.1055/s-2007-1016336. View